ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Brain Imaging Technology to Examine the Effects of Meditation

This study has been completed.

Sponsored by: National Center for Complementary and Alternative Medicine (NCCAM)
Information provided by: National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier: NCT00082160
  Purpose

The purpose of this study is to use brain imaging technology to identify the parts of the brain that are activated during meditation and to compare these parts to those activated during other activities. This study will also determine the effects of meditation on involuntary functions, such as breathing.


Condition Intervention
Healthy
Behavioral: Meditation
Procedure: Functional Magnetic Resonance Imaging

MedlinePlus related topics:   MRI Scans   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Natural History, Cross-Sectional, Defined Population, Prospective Study
Official Title:   fMRI Investigation of Meditation

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Enrollment:   60
Study Start Date:   July 2001
Estimated Study Completion Date:   June 2005

Detailed Description:

Meditation and relaxation-based interventions are becoming more widely accepted in clinical settings because of their low cost, low risk, and proven effectiveness as a complementary intervention in a wide range of diseases. Despite the success and growing use of relaxation-based treatments, few studies have addressed the basic mechanism by which these treatments work. This study will use functional magnetic resonance imaging (fMRI) to define the brain mechanisms underlying the meditative state, to differentiate this state from other states, and to determine how meditation-induced brain changes affect autonomic function.

Participants in this study will have an fMRI brain scan. Brain activity, breathing rate, and heart rate will be measured while the participant engages in three different activities: lying quietly, meditating, and mentally generating numbers.

  Eligibility
Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Daily practice of Vipassana or Kundalini meditation for at least 1 year and participation in at least one 1-week meditation retreat

Exclusion Criteria:

  • Current medical or psychological illness
  • Use of antidepressants, antianxiolytics, or compounds that alter cerebral blood flow
  • Claustrophobia
  • Pregnancy
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00082160

Locations
United States, Massachusetts
Massachusetts General Hospital    
      Boston, Massachusetts, United States, 02129

Sponsors and Collaborators

Investigators
Principal Investigator:     Sara Lazar, PhD     Massachusetts General Hospital Department of Psychiatry    
  More Information


Scientific American Frontiers program for which investigator was interviewed.  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   K01 AT000694-01
First Received:   April 30, 2004
Last Updated:   August 3, 2006
ClinicalTrials.gov Identifier:   NCT00082160
Health Authority:   United States: Federal Government

Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):
Meditation  
Relaxation  

Study placed in the following topic categories:
Healthy

ClinicalTrials.gov processed this record on September 22, 2008




Links to all studies - primarily for crawlers